Chris Cann, MD
@ChrisCannMD
GI Oncologist, Assistant Professor @FoxChaseCancer | @VUMCHemOnc Alum | Tweets are my own
ID:1270046331487301632
https://www.foxchase.org/christopher-cann 08-06-2020 17:33:48
119 Tweets
342 Followers
282 Following
โญ๏ธTHRILLED to host this meeting w/ my good friend Dr. Cathy Eng in beautiful Nashville. Join us as we have the LEADING thought leaders discuss the latest data including a special appearance by the Oncology Brothers
Register here๐
web.cvent.com/event/c61fd6ddโฆ
Dr. Cathy Eng David R. Spigel, MDโฆ
Woohoo! #NEO -RT Trial activated ahead of schedule and ready to open! Thanks to all of the support!
Dr. Carl J Brown ๐ CCTG NCI CTEP Clinical Research Josh Smith, MD, PhD, FACS Mark Whiteford Sharlene Gill, MD, MPH, MBA, FASCO Dr. Cathy Eng Karyn Goodman, MD, MS Jonathan Loree
A quick Xtorial:
1/10
So delighted to see our current and former Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center fellows come back for a visit!! Chris Cann, MD now at Fox Chase Cancer Center โ๏ธ in for the Colon Cancer Foundation #EAOCRC Summit!!! Vanderbilt Health Kathy Walsh, MD, MAEd #CancerResearch #crcsm #cancer
Toby Keith's death has raised a lot of questions about stomach cancer, including who it typically affects and how it's treated. Dr. Christopher Cann (Chris Cann, MD), of Fox Chase Cancer Center, shares important information on stomach cancer with Yahoo News: yhoo.it/491vxcn
The Vanderbilt-Ingram Cancer Center team #dimsum pregamed to support our Division Chief Dr. jordan berlin for his ๐คฉ๐๐ปPHENOMENAL discussion yesterday @asco #GI24 with 2 former Vanderbilt University Medical Center fellows Chris Cann, MD Marc Roth. Kristen Ciombor Rajiv Agarwal MD Brian Grieb MD, PhD Dana Cardin, MD #Cancer
Our Phase III CO.32 NEO-RT trial is finalized and will open next month. Stoked to meet up with study champs and team at #GI24 . Please check your NCTN menu to activate when ready. โฆCCTGโฉ โฆChris Cann, MDโฉ โฆNoam VanderWaldeโฉ โฆโฆDr. Carl J Brown ๐โฉ โฆ
Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemo Naive Patients with Unresectable Colorectal Liver Metastases โฆAnnalsSurgOncologyโฉ โฆSSATโฉ โฆโฉ โฆMichael Lidsky, MD, FACSโฉ โฆLee M. Ocuin MD, FACSโฉ link.springer.com/article/10.124โฆ
GREAT evening catching up with my @ecog NCI CTEP Clinical Research colleagues from Fox Chase Cancer Center Penn Medicine - Abramson Cancer Center Vanderbilt-Ingram Cancer Center and learning about new #CancerResearch concepts. We all have 1๏ธโฃ ๐ฏ #curing #cancer . Kristen Ciombor Laura Goff Efrat Dotan MD Michael Gibson, MD PhD Vanderbilt University. Chris Cann, MD
Great work validating a regression score to better predict pathological response, William A Hall, MD . Excited to apply this in our #NEO -RT phase III trial of STAGE I #rectalcancer . Dr. Carl J Brown ๐ NCI CTEP Clinical Research Chris Cann, MD Mark Whiteford Val Simianu
Fox Chase Cancer Center Welcomes Dr. Christopher G. Cann Chris Cann, MD Fox Chase Cancer Center #medtwitter ow.ly/2LRX50PCoar
So fortunate to start my career as a GI oncologist at the institution where my medical training began Lewis Katz School of Medicine Fox Chase Cancer Center
I was honored ๐๐ป to speak at Vanderbilt University Medical Center Grand Rounds yesterday on #earlyonset #colorectal #cancer . But MORE imp were these women: Mrs. Browning, a mom of 2 with stage 4 and also Ms. Tiffany Ewing, #MsBlackAlabama 2023 who lost her brother at 26 yo. THEIR stories need toโฆ
Before embarking Fox Chase Cancer Center, our ๐คฉ fellow Chris Cann, MD VUMC Department of Medicine stopped to say ๐๐ป and remind me of my failed #Superbowl wager and gave me this gift + a photo of himself + Pat's King of Steaks!! ๐๐ป๐๐ปPhiladelphia Eagles Luv it! ๐ #cancer #mentorship Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center
